Publication | Closed Access

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial

Gastrointestinal OncologyMedicineColorectal CancerMetastatic Colorectal CancerSurgeryNon-inferiority Phase 3Oxaliplatin Versus CapecitabineCancer TreatmentOncologyRadiation Oncology